Immediate Impact

3 by Nobel laureates 19 from Science/Nature 110 standout
Sub-graph 1 of 16

Citing Papers

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
2024 Standout
81 intermediate papers

Works of Bruno Daniele being referenced

Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
2019 Standout
Results of KEYNOTE-240: phase 3 study of pembrolizumab (Pembro) vs best supportive care (BSC) for second line therapy in advanced hepatocellular carcinoma (HCC).
2019
and 27 more

Author Peers

Author Last Decade Papers Cites
Bruno Daniele 4290 2620 1560 1974 196 8.1k
Adam C. Yopp 3847 3448 1720 3693 213 9.6k
Chih‐Hung Hsu 1871 2880 1754 1111 296 7.1k
Laura Rubbia‐Brandt 5769 3059 1103 3957 208 10.1k
Ronnie T. P. Poon 4396 3450 1719 2266 136 10.0k
Frankie Mo 4097 3140 1735 3284 184 10.0k
David J. Pinato 2093 2848 1213 1348 223 6.0k
Iwao Ikai 6538 2085 1328 3433 220 10.1k
Fabio Farinati 5738 1559 1703 4833 327 11.0k
Shuichiro Shiina 7180 1709 1294 5078 224 10.7k
Charles R. Scoggins 2551 5168 1870 1481 277 8.3k

All Works

Loading papers...

Rankless by CCL
2026